231 related articles for article (PubMed ID: 28089917)
21. p-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling.
García R; Nistal JF; Merino D; Price NL; Fernández-Hernando C; Beaumont J; González A; Hurlé MA; Villar AV
Biochim Biophys Acta; 2015 Jul; 1852(7):1520-30. PubMed ID: 25887159
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression.
Krishnan AV; Peehl DM; Feldman D
J Cell Biochem; 2003 Feb; 88(2):363-71. PubMed ID: 12520538
[TBL] [Abstract][Full Text] [Related]
23. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
24. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer.
Pudova EA; Krasnov GS; Nyushko KM; Kobelyatskaya AA; Savvateeva MV; Poloznikov AA; Dolotkazin DR; Klimina KM; Guvatova ZG; Simanovsky SA; Gladysh NS; Tokarev AT; Melnikova NV; Dmitriev AA; Alekseev BY; Kaprin AD; Kiseleva MV; Snezhkina AV; Kudryavtseva AV
BMC Med Genomics; 2020 Sep; 13(Suppl 8):129. PubMed ID: 32948204
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
26. High levels of PIWI-interacting RNAs are present in the small RNA landscape of prostate epithelium from vitamin D clinical trial specimens.
Baumann B; Lugli G; Gao S; Zenner M; Nonn L
Prostate; 2019 Jun; 79(8):840-855. PubMed ID: 30905091
[TBL] [Abstract][Full Text] [Related]
27. Identification of microRNA signature and potential pathway targets in prostate cancer.
Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB
Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835
[TBL] [Abstract][Full Text] [Related]
28. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
Barreto AM; Schwartz GG; Woodruff R; Cramer SD
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
[TBL] [Abstract][Full Text] [Related]
29. Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence.
Noren Hooten N; Martin-Montalvo A; Dluzen DF; Zhang Y; Bernier M; Zonderman AB; Becker KG; Gorospe M; de Cabo R; Evans MK
Aging Cell; 2016 Jun; 15(3):572-81. PubMed ID: 26990999
[TBL] [Abstract][Full Text] [Related]
30. Active vitamin D induces gene-specific hypomethylation in prostate cancer cells developing vitamin D resistance.
Lai GR; Lee YF; Yan SJ; Ting HJ
Am J Physiol Cell Physiol; 2020 May; 318(5):C836-C847. PubMed ID: 32159363
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
[TBL] [Abstract][Full Text] [Related]
32. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.
Spahn M; Kneitz S; Scholz CJ; Stenger N; Rüdiger T; Ströbel P; Riedmiller H; Kneitz B
Int J Cancer; 2010 Jul; 127(2):394-403. PubMed ID: 19585579
[TBL] [Abstract][Full Text] [Related]
33. Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients.
Wagner D; Trudel D; Van der Kwast T; Nonn L; Giangreco AA; Li D; Dias A; Cardoza M; Laszlo S; Hersey K; Klotz L; Finelli A; Fleshner N; Vieth R
J Clin Endocrinol Metab; 2013 Apr; 98(4):1498-507. PubMed ID: 23463655
[TBL] [Abstract][Full Text] [Related]
34. Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer.
Richardsen E; Andersen S; Al-Saad S; Rakaee M; Nordby Y; Pedersen MI; Ness N; Ingebriktsen LM; Fassina A; Taskén KA; Mills IG; Donnem T; Bremnes RM; Busund LT
Sci Rep; 2019 Jul; 9(1):10662. PubMed ID: 31337863
[TBL] [Abstract][Full Text] [Related]
35. Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
Ramírez-Moya J; Wert-Lamas L; Riesco-Eizaguirre G; Santisteban P
Oncogene; 2019 Jul; 38(27):5486-5499. PubMed ID: 30967628
[TBL] [Abstract][Full Text] [Related]
36. APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b.
Antoniali G; Dalla E; Mangiapane G; Zhao X; Jing X; Cheng Y; De Sanctis V; Ayyildiz D; Piazza S; Li M; Tell G
Cell Mol Life Sci; 2022 Jul; 79(8):446. PubMed ID: 35876890
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1993 May; 132(5):1952-60. PubMed ID: 7682937
[TBL] [Abstract][Full Text] [Related]
38. The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment.
Tang R; Qi Q; Wu R; Zhou X; Wu D; Zhou H; Mao Y; Li R; Liu C; Wang L; Chen W; Hua D; Zhang H; Wang W
Carcinogenesis; 2015 Aug; 36(8):867-75. PubMed ID: 25977444
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.
Alvarez-Díaz S; Valle N; Ferrer-Mayorga G; Lombardía L; Herrera M; Domínguez O; Segura MF; Bonilla F; Hernando E; Muñoz A
Hum Mol Genet; 2012 May; 21(10):2157-65. PubMed ID: 22328083
[TBL] [Abstract][Full Text] [Related]
40. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
